Utility of a new assay for carbohydrate-deficient transferrin (Biorad %CDT TIA) to monitor abstinence during a treatment outcome study.
about
Impaired homocysteine transsulfuration is an indicator of alcoholic liver disease.S-adenosyl-L-methionine treatment for alcoholic liver disease: a double-blinded, randomized, placebo-controlled trial.Combined effects of alcohol and hepatitis C: a secondary analysis of alcohol use biomarkers and high-risk behaviors from two medication trials for alcohol dependenceEffects of ondansetron in early- versus late-onset alcoholics: a prospective, open-label study.The validity of the laboratory marker combinations DOVER and QUVER to detect physician's diagnosis of at-risk drinking.DOVER and QUVER?New Marker Combinations to Detect and Monitor At-risk Drinking
P2860
Utility of a new assay for carbohydrate-deficient transferrin (Biorad %CDT TIA) to monitor abstinence during a treatment outcome study.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Utility of a new assay for car ...... ing a treatment outcome study.
@en
Utility of a new assay for carbohydrate-deficient transferrin
@nl
type
label
Utility of a new assay for car ...... ing a treatment outcome study.
@en
Utility of a new assay for carbohydrate-deficient transferrin
@nl
prefLabel
Utility of a new assay for car ...... ing a treatment outcome study.
@en
Utility of a new assay for carbohydrate-deficient transferrin
@nl
P2093
P1476
Utility of a new assay for car ...... ing a treatment outcome study.
@en
P2093
P2860
P304
P356
10.1111/J.1530-0277.2001.TB02355.X
P577
2001-09-01T00:00:00Z